Treatment of Behçet disease with oral roflumilast: an observational study
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llae284 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Rodrigo Peñuelas Leal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain. Hauptthemen laut MEDLINE: Cyclopropanes, Aminopyridines, Behcet Syndrome, Benzamides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Spanish Academy of Dermatology and Venereology.
Abstract (Originalsprache)
Background
Mucocutaneous Behçet disease often presents a therapeutic challenge. Roflumilast has shown promise in the treatment of other inflammatory dermatological conditions.
Objectives
The objective of this study was to evaluate the characteristics, effectiveness and safety of roflumilast in the treatment of Behçet disease-associated aphthosis in routine clinical practice.
Methods
We performed a single-cohort ambispective observational study. Eleven patients with Behçet disease treated with roflumilast participated. Data collection included demographic, clinical and outcome variables. Statistical analysis compared 12 weeks of treatment with roflumilast with a previous period without treatment and with a period when the previous treatment was used.
Results
During treatment with roflumilast, a reduction in flare-ups and oral ulcers was observed compared with the untreated period and the previous treatment period. A reduction in genital ulcers, pain and ulcer duration was observed between the without treatment period and the roflumilast treatment period. Adverse effects occurred in 54% of patients, most of which were self-limiting or manageable with dose adjustment. No patients withdrew treatment.
Conclusions
Roflumilast appears to be a potential option in the treatment of Behçet disease with favourable effectiveness, safety and tolerability profiles. Although further research is needed, roflumilast offers a promising treatment option for Behçet disease-associated aphthosis, which could improve the patients’ quality of life and address unmet therapeutic needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain.
- Gandia Public Health Centre, Gandía, Spain.
- Clínica Odontológica de Medicina Buccal, Valencia, Spain.
- Oral Medicine Department, University of Valencia, Valencia, Spain.
- Hospital Puerta del Mar, Cádiz, Spain.
- Department of Oral and Maxillofacial Surgery, Consorci Hospital General Universitari de Valencia, Valencia, Spain.
ORCID-Profile: Rodrigo Peñuelas Leal, Carolina Labrandero Hoyos, Leticia Bagán, Andrés Grau Echevarría, Malena Finello, Daniel Blaya Imbernon, José Bagán
Förderung
- Spanish Academy of Dermatology and Venereology
Zitieren
APA
Peñuelas Leal, R., Labrandero Hoyos, C., Peñuelas Ruiz, J. A., Bagán, L., Zaragoza Ninet, V., Sánchez Carazo, J. L., Pérez Pastor, G., Grau Echevarría, A., Esteve Martínez, A., Finello, M., Blaya Imbernon, D., Dios Guillán, V., Aguilar González, L., Bagán, J., & Alegre De Miquel, V. (2024). Treatment of Behçet disease with oral roflumilast: an observational study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae284
Vancouver
Peñuelas Leal R, Labrandero Hoyos C, Peñuelas Ruiz JA, Bagán L, Zaragoza Ninet V, Sánchez Carazo JL, et al. Treatment of Behçet disease with oral roflumilast: an observational study. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae284
BibTeX
@article{PeuelasLeal2024,
author = {Peñuelas Leal, Rodrigo and Labrandero Hoyos, Carolina and Peñuelas Ruiz, Jose Amancio and Bagán, Leticia and Zaragoza Ninet, Violeta and Sánchez Carazo, Jose Luis and Pérez Pastor, Gemma and Grau Echevarría, Andrés and Esteve Martínez, Altea and Finello, Malena and Blaya Imbernon, Daniel and Dios Guillán, Víctor and Aguilar González, Lucía and Bagán, José and Alegre De Miquel, Victor},
title = {Treatment of Behçet disease with oral roflumilast: an observational study},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llae284}
}
EUVIMED